Description
The Los Alamos National Laboratory is offering a technology licensing opportunity for a pH-switchable version of Protein G, which gently captures and releases antibodies using mild pH changes. This innovation has several key advantages, including gentle elution conditions, improved antibody stability and yield, a switchable binding mechanism, and cost-effectiveness. The technology has various market applications, including biopharmaceuticals, life sciences research, bioprocessing and manufacturing tools, and veterinary and agricultural biotech.
• The technology is at a development status of TRL 4.
• The technology has a US provisional/patent number of 10,954,275.
• The technology is available for licensing through exclusive and non-exclusive agreements.
• The laboratory offers a range of cutting-edge technologies and capabilities to provide companies with a competitive edge in the market.
Attached files
Contact
Marc Witkowski